Curzio Rüegg
Development and Clinical Validation of a Blood Test Based on 29-Gene Expression for Early Detection of Colorectal Cancer
Ciarloni L, Rüegg C, Maerten P, Vallet C, Beglinger C, Borovicka J, Meier R, van der Weg B, Kim T, Song S, Kim J, Myung S, Nichita C, Monnier-Benoit S, Imaizumi N, Ehrensberger S, Dorta G. Development and Clinical Validation of a Blood Test Based on 29-Gene Expression for Early Detection of Colorectal Cancer. Clin Cancer Res 2016; 22:4604-11.
Apr 28, 2016Development and Clinical Validation of a Blood Test Based on 29-Gene Expression for Early Detection of Colorectal Cancer
Apr 28, 2016Clin Cancer Res 2016; 22:4604-11
Ciarloni Laura, Rüegg Curzio, Maerten Philippe, Vallet Cédric, Beglinger Christoph, Borovicka Jan, Meier Rémy, van der Weg Boudewijn, Kim Tae Il, Song Si Young, Kim Joo Sung, Myung Seung-Jae, Nichita Cristina, Monnier-Benoit Sylvain, Imaizumi Natsuko, Ehrensberger Sahar Hosseinian, Dorta Gian
Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients
Cattin S, Fellay B, Pradervand S, Trojan A, Ruhstaller T, Rüegg C, Fürstenberger G. Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients. Oncotarget 2016; 7:11137-50.
Mar 8, 2016Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients
Mar 8, 2016Oncotarget 2016; 7:11137-50
Cattin Sarah, Fellay Benoît, Pradervand Sylvain, Trojan Andreas, Ruhstaller Thomas, Rüegg Curzio, Fürstenberger Gregor